Sort
64,565 grants matching “drug discovery”
Tau accumulation in the pedunculopontine tegmentum as an early node in Progressive Supranuclear Palsy pathogenesis
$1,808,406Stewart Donaldson Clark · State University Of New York At Buffalo · RF1 · FY2021 · NS
University of New Mexico Cancer Center Support
$1,808,387Cheryl L Willman · University Of New Mexico Health Scis Ctr · P30 · FY2013 · CA
Starve and Kill: Engineered Antigens Targeting Nutrient Acquisition Pathways Essential for Gonococcal Infection and Disease
$1,808,328Cynthia Nau Cornelissen · Georgia State University · U19 · FY2023 · AI
Discovery of an Orexin-1 receptor antagonist for treatment of cocaine addiction and dependence
$1,808,268Robert Cooke · Heptares Therapeutics, Ltd · R01 · FY2017 · DA
Immunobiology of Acute Environmental Asthma
$1,807,207David B Peden · Univ Of North Carolina Chapel Hill · U19 · FY2010 · AI
Resolving the bottleneck in antibiotic discovery
$1,807,186Kim Lewis · Northeastern University · P01 · FY2020 · AI
Systems Biology Approach to Redefine Susceptibility Testing and Treatment of MDR Pathogens in the Context of Host Immunity
$1,806,219Bernhard O Palsson · University Of California, San Diego · U01 · FY2020 · AI
Starve and Kill: Engineered Antigens Targeting Nutrient Acquisition Pathways Essential for Gonococcal Infection and Disease
$1,806,071Cynthia Nau Cornelissen · Georgia State University · U19 · FY2022 · AI
SPORE in Prostate Cancer
$1,805,886Sarki A. Abdulkadir · Northwestern University At Chicago · P50 · FY2024 · CA
Developing Novel Antibiotics Against Yersinia pestis
$1,805,783Losee Lucy Ling · Novobiotic Pharmaceuticals, Llc · R44 · FY2008 · AI
Molecular Mechanisms Of Growth Control And Carcinogenesis
$1,805,309J. Silvio Gutkind · National Institute Of Dental & Craniofacial Research · ZIA · FY2014 · DE
Vanderbilt NCDDDG for Discovery of Novel Treatments for Schizophrenia
$1,805,294P Jeffrey Conn · Vanderbilt University · U01 · FY2013 · MH
PHARMACEUTICAL RESEARCH CENTER
$1,803,858Henry Lewis · Florida Agricultural And Mechanical Univ · G12 · FY2007 · RR
Core 1
$1,803,820Mark A Musen · Stanford University · U54 · FY2010 · HG
Transcriptional Mechanisms of Drug Addiction
$1,803,476Eric J Nestler · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · DA
Transdisciplinary Program to Identify Novel Antifungal Targets and Inhibitors
$1,803,470John R. Perfect · Duke University · P01 · FY2017 · AI
New therapies for liver fibrosis and hyperproliferation in alpha1-AT deficiency
$1,803,138David H Perlmutter · University Of Pittsburgh At Pittsburgh · P01 · FY2015 · DK
Molecules and Pathways at the Coccidioides Host-Pathogen Interface
$1,803,075Anita Sil · University Of California, San Francisco · U19 · FY2025 · AI
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) Project 2: Preclinical Model for Antiepileptogenic Therapy Screening in Post-traumatic Epilepsy
$1,802,852Aristea S Galanopoulou · University Of Southern California · U54 · FY2021 · NS
600 MHz NMR spectrometer with 1.7mm micro-cryoprobe
$1,802,603Brendan Michael Duggan · University Of California, San Diego · S10 · FY2023 · OD
Discovery And Functional Genomics Of Environmental Response Genes
$1,801,873Douglas Bell · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES
Core 1
$1,800,369Mark A Musen · Stanford University · U54 · FY2011 · HG
CCI Phase I: NSF Center for Genomically Encoded Materials (C-GEM)
$1,800,000Alanna Schepartz · Yale University · · FY2017 · MPS
FUNCTIONAL GENOMICS OF THE BETA-CELL
$1,800,000University Of Pennsylvania · U01 · FY2002 · DK
Plasma proteomics in CHS and population biology
$1,799,932Bruce M Psaty · University Of Washington · R01 · FY2019 · HL